Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Musolino, G; Dovc, K; Boughton, CK; Tauschmann, M; Allen, JM; Nagl, K; Fritsch, M; Yong, J; Metcalfe, E; Schaeffer, D; Fichelle, M; Schierloh, U; Thiele, AG; Abt, D; Kojzar, H; Mader, JK; Slegtenhorst, S; Ashcroft, N; Wilinska, ME; Sibayan, J; Cohen, N; Kollman, C; Hofer, SE; Fröhlich-Reiterer, E; Kapellen, TM; Acerini, CL; de Beaufort, C; Campbell, F; Rami-Merhar, B; Hovorka, R; Kidsap Consortium.
Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
Pediatr Diabetes. 2019; 20(6):794-799
Doi: 10.1111/pedi.12872
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fritsch Maria
- Fröhlich-Reiterer Elke
- Kojzar Harald
- Mader Julia
- Tauschmann Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- To evaluate the experiences of families with very young children aged 1 to 7 years (inclusive) with type 1 diabetes using day-and-night hybrid closed-loop insulin delivery. Parents/caregivers of 20 children aged 1 to 7 years with type 1 diabetes completed a closed-loop experience survey following two 3-week periods of unrestricted day-and-night hybrid closed-loop insulin therapy using Cambridge FlorenceM system at home. Benefits, limitations, and improvements of closed-loop technology were explored. Responders reported reduced burden of diabetes management, less time spent managing diabetes, and improved quality of sleep with closed-loop. Ninety percent of the responders felt less worried about their child's glucose control using closed-loop. Size of study devices, battery performance and connectivity issues were identified as areas for improvement. Parents/caregivers wished for more options to input information to the system such as temporary glucose targets. Parents/caregivers of very young children reported important quality of life benefits associated with using closed-loop, supporting adoption of this technology in this population. © 2019 The Authors. Pediatric Diabetes published by John Wiley & Sons Ltd.
- Find related publications in this database (Keywords)
- artificial pancreas
- closed-loop insulin delivery
- type 1 diabetes
- very young children